China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd. – Trademark Portfolio
Entity Type: 99
China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The owner is based in Beijing.
102-2, 1/F, Bldg.# 23, Courtyard No. 3
Beijing 100095 , CN
Showing of trademarks Trademarks
Trademark Classifications
China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd. have?
China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd. has 1 U.S. trademark filed with the USPTO.
What trademark classes does China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd. file in?
China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What is China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd.'s trademark registration success rate?
China International Scientific Research Institute for Personal Protection Equipment (Beijing) Co.,ltd. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.